Biomedical Engineering Reference
In-Depth Information
[127] Li H, Qian Zm. Transferrin/transferrin receptor-mediated drug delivery. med Res Rev
2002; 22 :225-250.
[128] Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. curr
Opin chem Biol 2009; 13 :256-262.
[129] Walkey cD, Olsen JB, guo H, emili A, chan Wc. Nanoparticle size and surface chem-
istry determine serum protein adsorption and macrophage uptake. J Am chem Soc
2012; 134 :2139-2147.
[130] Fang H, Zhang K, Shen g, Wooley KL, Taylor JS. cationic shell-cross-linked knedel-like
(cScK) nanoparticles for highly efficient PNA delivery. mol Pharm 2009; 6 :615-626.
[131] Tyagi S, Alsmadi O. Imaging native β-actin mRNA in motile fibroblasts. Biophys J
2004; 87 :4153-4162.
[132] Behr JP. The proton sponge: a trick to enter cells the viruses did not exploit. chimia
1997; 51 :34-36.
[133] Akinc A, Thomas m, Klibanov Am, Langer R. exploring polyethylenimine-mediated
DNA transfection and the proton sponge hypothesis. J gene med 2005; 7 :657-663.
[134] cho YW, Kim JD, Park K. Polycation gene delivery systems: escape from endosomes
to cytosol. J Pharm Pharmacol 2003; 55 :721-734.
[135] cohen JL, Schubert S, Wich PR, cui L, cohen JA, mynar JL, Frechet Jm. Acid-
degradable cationic dextran particles for the delivery of siRNA therapeutics. Bioconjug
chem 2011; 22 :1056-1065.
[136] Hatakeyama H, Ito e, Akita H, Oishi m, Nagasaki Y, Futaki S, Harashima H. A pH-
sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene
silencing of siRNA-containing nanoparticles in vitro and in vivo . J control Release
2009; 139 :127-132.
[137] Nakase I, Kobayashi S, Futaki S. endosome-disruptive peptides for improving cyto-
solic delivery of bioactive macromolecules. Pept Sci 2010; 94 :763-770.
[138] Prigodich Ae, Randeria PS, Briley We, Kim NJ, Daniel WL, giljohann DA, mirkin
cA. multiplexed nanoflares: mRNA detection in live cells. Anal methods 2012; 84 :
2062-2066.
[139] Prigodich Ae, Seferos DS, massich mD, giljohann DA, Lane Bc, mirkin cA. Nano-
flares for mRNA regulation and detection. AcS Nano 2009; 3 :2147-2152.
[140] Seferos DS, giljohann DA, Hill HD, Prigodich Ae, mirkin cA. Nano-flares: probes for
transfection and mRNA detection in living cells. J Am chem Soc 2007; 129 :
15477-15479.
[141] Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles:
a review of in vitro and in vivo studies. chem Soc Rev 2011; 40 :1647-1671.
[142] Kim JK, choi KJ, Lee m, Jo mH, Kim S. molecular imaging of a cancer-targeting
theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-
conjugated nanoparticle. Biomaterials 2012; 33 :207-217.
[143] Kotula JW, Pratico eD, ming X, Nakagawa O, Juliano RL, Sullenger BA. Aptamer-
mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.
Nucleic Acid Ther 2012; 22 :187-195.
[144] Reyes-Reyes em, Teng Y, Bates PJ. A new paradigm for aptamer therapeutic AS1411
action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mech-
anism. cancer Res. 2010; 70 :8617-8629.
Search WWH ::




Custom Search